Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial - Concepedia

Concepedia

Publication | Open Access

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

DOI Full Paper Access

16

Citations

12

References

2025

Year

Norbert Heinrich, Veronique de Jager, Julia Dreisbach, Petra Gross-Demel, Susanne Schultz, Sina Gerbach, Rodney Dawson, Kim Narunsky, Letícia Muraro Wildner, Timothy D. McHugh,

The Lancet Microbe

Abstract

EDCTP2 programme; German Ministry for Education and Research; German Center for Infection Research; InfectControl; Bavarian Ministry for Science and the Arts; Swiss State Secretariat for Education, Research, and Innovation; and Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

References

	Year	Citations

Page 1